https://www.interpharma.ch/en/blog/3-questions-for-max-pahlow-member-interpharma-board-and-managing-director-janssen-switzerland/ 2026-02-26T07:36:24+00:00 https://www.interpharma.ch/wp-content/uploads/2024/01/klein_MAX-PAHLOW18753-1.jpg https://www.interpharma.ch/en/blog/johnson-johnson-sustainable-today-healthy-tomorrow/ 2026-02-26T07:37:42+00:00 https://www.interpharma.ch/wp-content/uploads/2023/02/janssen-SDG-2023-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-1-notwendige-tierversuche-und-die-uebertragbarkeit-der-ergebnisse-auf-den-menschen/ 2026-02-26T07:38:10+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/en/blog/3-questions-to-colleen-kamrad-vice-president-and-general-manager-of-gsk-switzerland/ 2026-02-26T07:38:44+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-056-scaled.jpeg https://www.interpharma.ch/wp-content/uploads/2026/02/image-18.png https://www.interpharma.ch/en/blog/3-fragen-an-daniel-weber-country-head-switzerland-boehringer-ingelheim/ 2026-02-26T07:39:22+00:00 https://www.interpharma.ch/wp-content/uploads/2021/12/Daniel-Meyer-Boehringer-Ingelheim.jpg https://www.interpharma.ch/en/blog/partnerschaft-zwischen-der-british-swiss-chamber-of-commerce-und-interpharma/ 2026-02-26T07:39:56+00:00 https://www.interpharma.ch/wp-content/uploads/2021/08/British-Swiss-Chamber.png https://www.interpharma.ch/en/blog/neue-interpharma-boardmitglieder-3-fragen-an-christophe-griolet-general-manager-gilead-switzerland/ 2026-02-26T07:40:30+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-054-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2025/06/20250613_iph_hightech_pharmaproduktion_broschuere_a4_web_EN-pdf.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-member-mads-stoustrup-general-manager-novo-nordisk-switzerland/ 2026-02-26T07:42:31+00:00 https://www.interpharma.ch/wp-content/uploads/2020/04/WJL54596-Mats-scaled.jpg https://www.interpharma.ch/en/blog/foreign-price-comparison-of-medicines-price-difference-to-foreign-countries-for-patented-medicines-continues-to-decrease/ 2026-02-26T08:30:42+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/APV-Bild-1-1024x643-1.png https://www.interpharma.ch/wp-content/uploads/2022/03/image-4.png https://www.interpharma.ch/wp-content/uploads/2022/04/20220325_iph_Jahresbericht_2021_d_web-1-pdf-1.jpg https://www.interpharma.ch/en/blog/three-questions-for-the-new-chair-of-the-market-committee-myriam-deleone-managing-director-of-amgen-switzerland/ 2026-02-26T09:31:02+00:00 https://www.interpharma.ch/wp-content/uploads/add-from-server-reloaded/L1040074-2-Bearbeitet-scaled-e1765550553239.jpg https://interpharma.ch/wp-content/uploads/2025/12/L1040074-2-Bearbeitet-1-683x1024.jpg https://www.interpharma.ch/en/?p=11980 2026-02-26T09:31:05+00:00 https://www.interpharma.ch/en/blog/switzerlands-top-pharma-lobbyistunpacks-trumps-corporate-deals/ 2026-02-26T09:31:05+00:00 https://www.interpharma.ch/wp-content/uploads/2025/10/427_Interpharma-scaled.jpg https://www.interpharma.ch/en/blog/press-release-switzerland-continues-to-lose-ground-in-access-to-new-medicines-supply-and-location-at-risk/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2021/02/iStock-1064859060-scaled.jpg https://www.interpharma.ch/en/blog/three-questions-to-our-new-board-members-president-region-europe-at-novartis-und-vice-president-of-the-interpharma-board/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Beitragsbild_3-Fragen-an-Iris-Zemzoum.png https://interpharma.ch/wp-content/uploads/2025/06/Photo-Iris-Zemzoum.jpg https://www.interpharma.ch/en/blog/press-release-bilaterals-iii-stable-relationships-with-our-principal-trading-partner/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/en/blog/press-release-research-based-industries-acknowledge-the-signing-of-free-trade-agreement-with-mercosur/ 2026-02-26T09:31:06+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/EFTA-Mercosur.jpg https://interpharma.ch/wp-content/uploads/2025/07/image.png https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca/ 2026-02-26T09:31:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-scaled.jpg https://interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-1024x683.jpg https://www.interpharma.ch/en/?p=12066 2026-02-26T09:31:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild_Annette-Luther_3-Fraqgen-an.png https://interpharma.ch/wp-content/uploads/2025/05/Annette_Luther_Roche_02-819x1024.jpg https://www.interpharma.ch/en/blog/three-questions-to-our-new-board-members-linn-mandahl-vice-president-europe-region-south-at-abbvie/ 2026-02-26T09:31:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-Linn-Mandahl-1.png https://interpharma.ch/wp-content/uploads/2025/05/Linn-Mandahl-1-683x1024.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-members-david-traub-managing-director-of-novartis-pharma-schweiz-ag/ 2026-02-26T09:31:08+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-David-Traub-1.png https://interpharma.ch/wp-content/uploads/2025/05/David-Traub-748x1024.jpg https://www.interpharma.ch/en/blog/prevention-in-the-swiss-healthcare-system/ 2026-02-26T09:31:08+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bildschirmfoto-2022-03-21-um-11.51.57-1.jpg https://interpharma.ch/wp-content/uploads/2025/04/Bildschirmfoto-2022-03-21-um-11.51.57-1024x594.jpg https://www.interpharma.ch/en/blog/access-to-innovation-in-prevention-and-early-detection/ 2026-02-26T09:31:09+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/iStock_Herz_Praevention.jpg https://www.interpharma.ch/en/blog/use-of-data-as-a-key-to-more-targeted-prevention/ 2026-02-26T09:31:09+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/NF_AI4HealthyCities_Skyline_Banner-scaled.jpg https://www.interpharma.ch/en/blog/holistic-strategy-and-coordination/ 2026-02-26T09:31:09+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bild_Blogbeitrag-2.png https://www.interpharma.ch/en/blog/targeted-prevention-and-early-detection-are-the-key-to-long-term-success/ 2026-02-26T09:32:09+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Beitragsbild-deutsch.png https://www.interpharma.ch/en/blog/prevention-as-part-of-a-sustainable-swiss-healthcare-system/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Prinzipien-des-Gesundheitswesens_slide-scaled.png https://www.interpharma.ch/en/blog/pharmaceutical-industry-day-2025-making-the-swiss-pharmaceutical-industry-more-competitive/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/en/blog/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma/ 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Ausschnitt-Jahresbericht-2024.jpg https://www.interpharma.ch/en/?p=12164 2026-02-26T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2025/02/Manuela-Stier_Bild-2.jpg https://interpharma.ch/wp-content/uploads/2025/02/Manuela-Stier_Bild-1-672x1024.jpg https://www.interpharma.ch/en/blog/lung-on-chip-eine-humane-loesung-zur-pruefung-von-lungenfunktion-und-toxizitaet/ 2026-02-26T09:32:12+00:00 https://www.interpharma.ch/wp-content/uploads/2025/01/2021-3RCC-026-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-9-neue-therapien-im-fokus-wie-bahnbrechende-tierversuchsfreie-forschung-den-weg-zur-behandlung-der-fettleber-ebnet/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/11/BIld-Artikel-9-Liver_organoid-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-8-koennen-insekten-emotionen-empfinden-neue-studien-entfachen-eine-debatte-ueber-die-schmerzempfindlichkeit-wirbelloser-lebewesen/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-8-AdobeStock_741829926-scaled.jpeg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-7-neue-methode-simuliert-echte-gewebestrukturen-ein-grosser-schritt-fuer-die-zukunft-der-krebsforschung/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-7-pdac_ck7_dapi_day13.png https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-6-wachstumswunder-wie-radial-verteilte-stammzellen-das-wachstum-von-organoiden-foerdern/ 2026-02-26T09:32:14+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Bild-Artikel-6-OCTOPUS-THUMBNAIL.png https://www.interpharma.ch/en/blog/hightech-pharmaproduktion-in-der-schweizer-pharmaindustrie-innovation-und-effizienz/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2020/08/APV-Bild2.png https://www.interpharma.ch/en/blog/naeher-an-der-loesung-des-praeeklampsie-raetsels-in-vitro-trophoblastzellen-in-aktion/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/2023-Swiss3RCC-003-low.jpg https://www.interpharma.ch/en/blog/press-release-health-panorama-2024-fact-based-contribution-to-the-dialogue-for-a-sustainable-healthcare-system/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/Front-DE.png https://interpharma.ch/wp-content/uploads/2024/08/In-Kuerze-1024x666.png https://www.interpharma.ch/en/blog/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-3-das-gehirn-und-die-zeit-was-fruchtfliegen-uns-verraten/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm.png https://interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm-1024x576.png https://www.interpharma.ch/en/blog/sommerblogserie-mit-dem-3rcc-teil-5-3d-gedrucktes-modell-revolutioniert-die-krebsforschung/ 2026-02-26T09:32:15+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/iStock-1530776415.jpg https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-2-erforschung-von-blutstammzellen-erkenntnisse-aus-bildgebenden-verfahren-ueber-die-entwicklung-von-zebrafischen/ 2026-02-26T09:32:16+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-1-wie-darmbakterien-das-sozialverhalten-von-zebrafischen-beeinflussen/ 2026-02-26T09:32:16+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-schick-president-merck-switzerland/ 2026-02-26T09:32:17+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Schick_1_klein.jpg https://interpharma.ch/wp-content/uploads/2024/07/Schick_1-1024x1024.jpg https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-anne-mette-wiis-vogelsang-cvp-general-manager-novo-nordisk-switzerland/ 2026-02-26T09:32:17+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/AMWV-Portrait-klein_Oct-2023-scaled.jpg https://interpharma.ch/wp-content/uploads/2024/06/AMWV-Portrait-gross_Oct-2023-768x1024.jpg https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-dimitri-gitas-general-manager-switzerland-msd/ 2026-02-26T09:32:18+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/klein-Gitas_Dimitri_MD_146_vari-scaled.jpg https://interpharma.ch/wp-content/uploads/2024/06/Gitas_Dimitri_MD_146_vari-683x1024.jpg https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-daniel-weber-country-head-switzerland-boehringer-ingelheim/ 2026-02-26T09:32:18+00:00 https://www.interpharma.ch/wp-content/uploads/2024/05/Lugano-3.jpg https://interpharma.ch/wp-content/uploads/2024/05/Lugano-3-791x1024.jpg https://www.interpharma.ch/en/blog/3-questions-for-max-pahlow-member-interpharma-board-and-managing-director-janssen-switzerland/ 2026-02-26T09:32:40+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/klein_MAX-PAHLOW18753.jpg https://www.interpharma.ch/en/blog/press-release-animal-welfare-report-2023-advancing-the-principles-of-the-3rs-with-the-digitalization-of-animal-research/ 2026-02-26T09:32:40+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Animal-Welfare.jpg https://www.interpharma.ch/en/blog/serie-sustainable-development-goals-johnson-johnson-engagiert-sich-fuer-klimaschutz-mit-konkreten-projekten/ 2026-02-26T09:32:43+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-076-scaled.jpg https://www.interpharma.ch/en/blog/health-panorama-2023-heres-to-another-90-years-of-innovation-and-quality-for-the-healthcare-system/ 2026-02-26T09:32:43+00:00 https://www.interpharma.ch/wp-content/uploads/2023/08/Cover-DE.png https://interpharma.ch/wp-content/uploads/2023/08/Bullets-1.png https://www.interpharma.ch/en/blog/internationaler-tag-der-klinischen-forschung-3-fragen-an-prof-dr-med-miklos-pless-praesident-sakk/ 2026-02-26T09:32:45+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/Pless-Miklos.jpg https://www.interpharma.ch/en/blog/3-fragen-an-thorsten-hein-mitglied-interpharma-board-und-country-division-head-pharmaceuticals-bayer-schweiz/ 2026-02-26T09:32:45+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/ThorstenHein.neu_.png https://www.interpharma.ch/en/blog/3-fragen-an-graham-dorey-mitglied-interpharma-board-und-general-manager-schweiz-biogen/ 2026-02-26T09:32:47+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/dorey_741_highres-1-scaled.jpg https://www.interpharma.ch/en/blog/3-fragen-an-max-pahlow-mitglied-interpharma-board-und-managing-director-janssen-switzerland/ 2026-02-26T09:32:47+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/klein_MAX-PAHLOW18753.jpg https://www.interpharma.ch/en/blog/medienmitteilung-ueberarbeitung-der-allgemeinen-eu-arzneimittelvorschriften-schwerwiegende-konsequenzen-fuer-die-schweiz-erwartet/ 2026-02-26T09:32:47+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/en/blog/3-fragen-an-pierre-morneau-general-manager-takeda-schweiz-takeda-pharma-ag-vice-chair-innovation-hub-committee/ 2026-02-26T09:32:47+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/896_Interpharma-scaled.jpg https://www.interpharma.ch/en/blog/press-release-interpharma-90-years-of-innovation-and-commitment-to-patients-in-switzerland/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Logo_90-Jahre.jpg https://www.interpharma.ch/en/blog/medienmitteilung-generalversammlung-von-interpharma/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Jahresbericht-2022-Titelbild-D.jpg https://www.interpharma.ch/en/blog/medienmitteilung-europabefragung-2023-schweizer-bevoelkerung-unterstuetzt-bilaterale-noch-staerker-und-erwartet-vom-bundesrat-einen-konkreten-vorschlag/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Europabefragung-2023.jpg https://www.interpharma.ch/en/blog/johnson-johnson-sustainable-today-healthy-tomorrow/ 2026-02-26T09:32:48+00:00 https://www.interpharma.ch/wp-content/uploads/2023/02/janssen-SDG-2023-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-2-notwendige-tierversuche-und-die-ubertragbarkeit-der-ergebnisse-auf-den-menschen-ii/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-1-notwendige-tierversuche-und-die-uebertragbarkeit-der-ergebnisse-auf-den-menschen/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/en/blog/press-release-a-success-for-switzerland-as-a-production-center-and-for-security-of-supply-in-switzerland/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/en/blog/trips-briefly-explained/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/en/blog/gute-nachrichten-fuer-den-produktionsstandort-schweiz/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/en/?p=12777 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-3-auf-dem-weg-vom-zuchtbetrieb-zum-labor-steht-das-tierwohl-an-erster-stelle/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/en/blog/blogserie-amr-awareness-week-2022-teil-3-msd-one-health/ 2026-02-26T09:32:50+00:00 https://www.interpharma.ch/en/blog/3-fragen-an-leila-schwery-bou-diab-vorsitzende-des-innovation-hub-committee-von-interpharma-vp-manufacturing-technical-operations-janssen-johnson-johnson/ 2026-02-26T09:33:56+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Leila-picture.jpg https://www.interpharma.ch/en/blog/3-questions-to-colleen-kamrad-vice-president-and-general-manager-of-gsk-switzerland/ 2026-02-26T09:33:59+00:00 https://www.interpharma.ch/wp-content/uploads/2021/06/Colleen-Kamrad-scaled.jpeg https://www.interpharma.ch/wp-content/uploads/2026/02/image-18.png https://www.interpharma.ch/en/blog/3-fragen-an-urs-voegeli-managing-director-janssen-schweiz-vp-johnson-johnson-schweiz-2/ 2026-02-26T09:33:59+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/klein_JANSSEN-CILAG-URS-VOeGELI18412.jpg https://interpharma.ch/wp-content/uploads/2022/06/klein_JANSSEN-CILAG-URS-VOeGELI18412.jpg https://www.interpharma.ch/en/blog/3-fragen-an-leila-schwery-bou-diab/ 2026-02-26T09:34:00+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Leila-picture.jpg https://www.interpharma.ch/en/blog/sichere-supply-chains-europa-muss-zusammenarbeiten/ 2026-02-26T09:34:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/en/blog/3-fragen-an-daniel-weber-country-head-switzerland-boehringer-ingelheim/ 2026-02-26T09:34:51+00:00 https://www.interpharma.ch/wp-content/uploads/2021/12/Daniel-Meyer-Boehringer-Ingelheim.jpg https://www.interpharma.ch/en/blog/partnerschaft-zwischen-der-british-swiss-chamber-of-commerce-und-interpharma/ 2026-02-26T09:34:54+00:00 https://www.interpharma.ch/wp-content/uploads/2021/08/British-Swiss-Chamber.png https://www.interpharma.ch/en/blog/3-fragen-an-colleen-kamrad-vice-president-general-manager-gsk-switzerland/ 2026-02-26T09:34:55+00:00 https://www.interpharma.ch/wp-content/uploads/2021/06/Colleen-Kamrad-scaled.jpeg https://www.interpharma.ch/wp-content/uploads/2026/02/image-17.png https://www.interpharma.ch/en/blog/neue-interpharma-boardmitglieder-3-fragen-an-christophe-griolet-general-manager-gilead-switzerland/ 2026-02-26T09:34:58+00:00 https://www.interpharma.ch/wp-content/uploads/2021/04/Christophe-Griolet-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2025/06/20250613_iph_hightech_pharmaproduktion_broschuere_a4_web_EN-pdf.jpg https://www.interpharma.ch/en/blog/unser-engagement-in-der-besonderen-lage-5-5-produktionsstandort/ 2026-02-26T09:35:20+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_05.jpg https://www.interpharma.ch/wp-content/uploads/2020/11/Animal-Welfare-Report-2021-EN1.pdf https://www.interpharma.ch/en/blog/neue-zahlen-und-fakten-zum-gesundheitswesen-und-zur-pharmalandschaft-schweiz/ 2026-02-26T09:35:21+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/thmb-Panorama.png https://www.interpharma.ch/en/blog/unser-engagement-in-der-besonderen-lage-diagnostika-medikamente-impfstoffe/ 2026-02-26T09:35:22+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_01.jpg https://www.interpharma.ch/wp-content/uploads/2020/11/Titelbild-AWR-2021-F.png https://www.interpharma.ch/en/blog/three-questions-to-johanna-friedl-naderer-president-europe-canada-partner-markets-biogen/ 2026-02-26T09:35:24+00:00 https://www.interpharma.ch/wp-content/uploads/2020/06/Johanna-Naderer.jpg https://www.interpharma.ch/wp-content/uploads/2019/04/AdobeStock_136935043-scaled.jpeg https://www.interpharma.ch/en/blog/three-questions-to-nicholas-franco-from-johnson-johnson/ 2026-02-26T09:35:25+00:00 https://www.interpharma.ch/wp-content/uploads/2020/06/Nicolas-Franco-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2022/12/Komplexitaet_iStock-1061344204.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-member-mads-stoustrup-general-manager-novo-nordisk-switzerland/ 2026-02-26T09:35:40+00:00 https://www.interpharma.ch/wp-content/uploads/2020/04/WJL54596-Mats-scaled.jpg https://www.interpharma.ch/en/blog/sustainable-development-goals-bayer-entwickelt-gemeinsam-mit-schweizer-institut-tph-behandlung-gegen-wurmerkrankungen-im-menschen/ 2026-02-27T10:12:50+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/female_doctor_examining_african_child-scaled.jpeg https://interpharma.ch/wp-content/uploads/2023/11/doctor_examining_african_girl-1-1024x683.jpeg https://www.interpharma.ch/en/blog/johnson-johnson-sustainable-today-healthy-tomorrow/ 2026-02-27T10:17:35+00:00 https://www.interpharma.ch/wp-content/uploads/2023/02/janssen-SDG-2023-scaled.jpg https://www.interpharma.ch/en/blog/serie-sustainable-development-goals-johnson-johnson-engagiert-sich-fuer-klimaschutz-mit-konkreten-projekten/ 2026-02-27T10:23:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-076-scaled.jpg https://www.interpharma.ch/en/blog/sustainable-development-goals-bayer-entwickelt-gemeinsam-mit-schweizer-institut-tph-behandlung-gegen-wurmerkrankungen-im-menschen/ 2026-02-27T10:26:07+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/female_doctor_examining_african_child-scaled.jpeg https://interpharma.ch/wp-content/uploads/2023/11/doctor_examining_african_girl-2-1024x683.jpeg https://www.interpharma.ch/en/blog/sustainable-development-goals-bayer-entwickelt-gemeinsam-mit-schweizer-institut-tph-behandlung-gegen-wurmerkrankungen-im-menschen/ 2026-02-27T10:27:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/female_doctor_examining_african_child-scaled.jpeg https://interpharma.ch/wp-content/uploads/2023/11/doctor_examining_african_girl-1024x683.jpeg https://www.interpharma.ch/en/blog/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda/ 2026-03-03T08:36:13+00:00 https://www.interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg https://interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-2-1024x768.jpg https://www.interpharma.ch/en/blog/three-questions-for-the-new-chair-of-the-market-committee-myriam-deleone-managing-director-of-amgen-switzerland/ 2026-03-03T08:36:48+00:00 https://www.interpharma.ch/wp-content/uploads/add-from-server-reloaded/L1040074-2-Bearbeitet-scaled-e1765550553239.jpg https://interpharma.ch/wp-content/uploads/2025/12/L1040074-2-Bearbeitet-683x1024.jpg https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-2-the-quiet-advance-of-antimicrobial-resistance-amr/ 2026-03-03T08:37:25+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-052.png https://www.interpharma.ch/en/blog/switzerlands-top-pharma-lobbyistunpacks-trumps-corporate-deals/ 2026-03-03T08:39:20+00:00 https://www.interpharma.ch/wp-content/uploads/2025/10/427_Interpharma-scaled.jpg https://www.interpharma.ch/en/blog/press-release-bilaterals-iii-stable-relationships-with-our-principal-trading-partner/ 2026-03-03T08:39:33+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/en/blog/press-release-research-based-industries-acknowledge-the-signing-of-free-trade-agreement-with-mercosur/ 2026-03-03T08:39:47+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/EFTA-Mercosur.jpg https://interpharma.ch/wp-content/uploads/2025/07/image-1.png https://www.interpharma.ch/en/blog/press-release-switzerland-continues-to-lose-ground-in-access-to-new-medicines-supply-and-location-at-risk/ 2026-03-03T08:40:03+00:00 https://www.interpharma.ch/wp-content/uploads/2021/02/iStock-1064859060-scaled.jpg https://www.interpharma.ch/en/blog/three-questions-to-our-new-board-members-president-region-europe-at-novartis-und-vice-president-of-the-interpharma-board/ 2026-03-03T08:40:33+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Beitragsbild_3-Fragen-an-Iris-Zemzoum.png https://interpharma.ch/wp-content/uploads/2025/06/Photo-Iris-Zemzoum-1.jpg https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca/ 2026-03-03T08:40:50+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-scaled.jpg https://interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-1024x683.jpg https://www.interpharma.ch/en/blog/three-questions-to-our-new-board-members-linn-mandahl-vice-president-europe-region-south-at-abbvie/ 2026-03-03T08:41:40+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-Linn-Mandahl-1.png https://interpharma.ch/wp-content/uploads/2025/05/Linn-Mandahl-2-683x1024.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-members-david-traub-managing-director-of-novartis-pharma-schweiz-ag/ 2026-03-03T08:41:56+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-David-Traub-1.png https://interpharma.ch/wp-content/uploads/2025/05/David-Traub-2-748x1024.jpg https://www.interpharma.ch/en/blog/prevention-in-the-swiss-healthcare-system/ 2026-03-03T08:42:51+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bildschirmfoto-2022-03-21-um-11.51.57-1.jpg https://interpharma.ch/wp-content/uploads/2025/04/Bildschirmfoto-2022-03-21-um-11.51.57-3-1024x594.jpg https://www.interpharma.ch/en/blog/access-to-innovation-in-prevention-and-early-detection/ 2026-03-03T08:43:07+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/iStock_Herz_Praevention.jpg https://www.interpharma.ch/en/blog/use-of-data-as-a-key-to-more-targeted-prevention/ 2026-03-03T08:43:20+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/NF_AI4HealthyCities_Skyline_Banner-scaled.jpg https://www.interpharma.ch/en/blog/holistic-strategy-and-coordination/ 2026-03-03T08:43:32+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bild_Blogbeitrag-2.png https://www.interpharma.ch/en/blog/targeted-prevention-and-early-detection-are-the-key-to-long-term-success/ 2026-03-03T08:43:53+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Beitragsbild-englisch-1.png https://www.interpharma.ch/en/blog/prevention-as-part-of-a-sustainable-swiss-healthcare-system/ 2026-03-03T08:44:05+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-080-scaled.png https://www.interpharma.ch/en/blog/pharmaceutical-industry-day-2025-making-the-swiss-pharmaceutical-industry-more-competitive/ 2026-03-03T08:44:22+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/en/blog/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma/ 2026-03-03T08:44:33+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Ausschnitt-Jahresbericht-2024.jpg https://www.interpharma.ch/en/blog/lung-on-chip-eine-humane-loesung-zur-pruefung-von-lungenfunktion-und-toxizitaet/ 2026-03-03T08:45:12+00:00 https://www.interpharma.ch/wp-content/uploads/2025/01/2021-3RCC-026-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-9-neue-therapien-im-fokus-wie-bahnbrechende-tierversuchsfreie-forschung-den-weg-zur-behandlung-der-fettleber-ebnet/ 2026-03-03T08:45:24+00:00 https://www.interpharma.ch/wp-content/uploads/2024/11/BIld-Artikel-9-Liver_organoid-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-8-koennen-insekten-emotionen-empfinden-neue-studien-entfachen-eine-debatte-ueber-die-schmerzempfindlichkeit-wirbelloser-lebewesen/ 2026-03-03T08:45:41+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-8-AdobeStock_741829926-scaled.jpeg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-7-neue-methode-simuliert-echte-gewebestrukturen-ein-grosser-schritt-fuer-die-zukunft-der-krebsforschung/ 2026-03-03T08:45:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-7-pdac_ck7_dapi_day13.png https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-6-wachstumswunder-wie-radial-verteilte-stammzellen-das-wachstum-von-organoiden-foerdern/ 2026-03-03T08:46:01+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Bild-Artikel-6-OCTOPUS-THUMBNAIL.png https://www.interpharma.ch/en/blog/sommerblogserie-mit-dem-3rcc-teil-5-3d-gedrucktes-modell-revolutioniert-die-krebsforschung/ 2026-03-03T08:46:12+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/iStock-1530776415.jpg https://www.interpharma.ch/en/blog/hightech-pharmaproduktion-in-der-schweizer-pharmaindustrie-innovation-und-effizienz/ 2026-03-03T08:46:27+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Anzeigebild-EN.jpg https://www.interpharma.ch/en/blog/naeher-an-der-loesung-des-praeeklampsie-raetsels-in-vitro-trophoblastzellen-in-aktion/ 2026-03-03T08:46:39+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/2023-Swiss3RCC-003-low.jpg https://www.interpharma.ch/en/blog/press-release-health-panorama-2024-fact-based-contribution-to-the-dialogue-for-a-sustainable-healthcare-system/ 2026-03-03T08:46:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/Front-EN.png https://interpharma.ch/wp-content/uploads/2024/08/Key-facts-1-1024x669.png https://www.interpharma.ch/en/blog/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit/ 2026-03-03T08:47:01+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-3-das-gehirn-und-die-zeit-was-fruchtfliegen-uns-verraten/ 2026-03-03T08:47:19+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm.png https://interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm.png https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-2-erforschung-von-blutstammzellen-erkenntnisse-aus-bildgebenden-verfahren-ueber-die-entwicklung-von-zebrafischen/ 2026-03-03T08:47:30+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-1-wie-darmbakterien-das-sozialverhalten-von-zebrafischen-beeinflussen/ 2026-03-03T08:47:41+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-schick-president-merck-switzerland/ 2026-03-03T08:47:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Schick_1_klein.jpg https://interpharma.ch/wp-content/uploads/2024/07/Schick_1.jpg https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-anne-mette-wiis-vogelsang-cvp-general-manager-novo-nordisk-switzerland/ 2026-03-03T08:48:03+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/AMWV-Portrait-klein_Oct-2023-scaled.jpg https://interpharma.ch/wp-content/uploads/2024/06/AMWV-Portrait-gross_Oct-2023-768x1024.jpg https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-dimitri-gitas-general-manager-switzerland-msd/ 2026-03-03T08:48:18+00:00 https://www.interpharma.ch/wp-content/uploads/2024/06/klein-Gitas_Dimitri_MD_146_vari-scaled.jpg https://interpharma.ch/wp-content/uploads/2024/06/Gitas_Dimitri_MD_146_vari-683x1024.jpg https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-daniel-weber-country-head-switzerland-boehringer-ingelheim/ 2026-03-03T08:48:32+00:00 https://www.interpharma.ch/wp-content/uploads/2024/05/Lugano-3.jpg https://interpharma.ch/wp-content/uploads/2024/05/Lugano-3.jpg https://www.interpharma.ch/en/blog/press-release-animal-welfare-report-2023-advancing-the-principles-of-the-3rs-with-the-digitalization-of-animal-research/ 2026-03-03T08:48:49+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Animal-Welfare-1.jpg https://www.interpharma.ch/en/blog/health-panorama-2023-heres-to-another-90-years-of-innovation-and-quality-for-the-healthcare-system/ 2026-03-03T08:49:05+00:00 https://www.interpharma.ch/wp-content/uploads/2023/08/Cover_EN.png https://interpharma.ch/wp-content/uploads/2023/08/Bullets-EN.png https://www.interpharma.ch/en/blog/internationaler-tag-der-klinischen-forschung-3-fragen-an-prof-dr-med-miklos-pless-praesident-sakk/ 2026-03-03T08:49:17+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/Pless-Miklos.jpg https://www.interpharma.ch/en/blog/3-fragen-an-thorsten-hein-mitglied-interpharma-board-und-country-division-head-pharmaceuticals-bayer-schweiz/ 2026-03-03T08:49:28+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/ThorstenHein.neu_.png https://www.interpharma.ch/en/blog/3-fragen-an-graham-dorey-mitglied-interpharma-board-und-general-manager-schweiz-biogen/ 2026-03-03T08:49:39+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/dorey_741_highres-1-scaled.jpg https://www.interpharma.ch/en/blog/3-fragen-an-max-pahlow-mitglied-interpharma-board-und-managing-director-janssen-switzerland/ 2026-03-03T08:49:49+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/klein_MAX-PAHLOW18753.jpg https://www.interpharma.ch/en/blog/medienmitteilung-ueberarbeitung-der-allgemeinen-eu-arzneimittelvorschriften-schwerwiegende-konsequenzen-fuer-die-schweiz-erwartet/ 2026-03-03T08:50:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/en/blog/3-fragen-an-pierre-morneau-general-manager-takeda-schweiz-takeda-pharma-ag-vice-chair-innovation-hub-committee/ 2026-03-03T08:50:11+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/896_Interpharma-scaled.jpg https://www.interpharma.ch/en/blog/interactive-map-of-switzerland-as-a-pharma-hub/ 2026-03-03T08:50:22+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/thm_EN.jpg https://www.interpharma.ch/en/blog/press-release-interpharma-90-years-of-innovation-and-commitment-to-patients-in-switzerland/ 2026-03-03T08:50:50+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Logo_90-Jahre.jpg https://www.interpharma.ch/en/blog/medienmitteilung-generalversammlung-von-interpharma/ 2026-03-03T08:51:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Jahresbericht-2022-Titelbild-D.jpg https://www.interpharma.ch/en/blog/medienmitteilung-europabefragung-2023-schweizer-bevoelkerung-unterstuetzt-bilaterale-noch-staerker-und-erwartet-vom-bundesrat-einen-konkreten-vorschlag/ 2026-03-03T08:51:12+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Europabefragung-2023.jpg https://www.interpharma.ch/en/blog/press-release-a-success-for-switzerland-as-a-production-center-and-for-security-of-supply-in-switzerland/ 2026-03-03T08:51:33+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/CH-USA-scaled.jpg https://www.interpharma.ch/en/blog/trips-briefly-explained/ 2026-03-03T08:51:44+00:00 https://www.interpharma.ch/wp-content/uploads/2021/10/IP-scaled.jpg https://www.interpharma.ch/en/blog/gute-nachrichten-fuer-den-produktionsstandort-schweiz/ 2026-03-03T08:52:01+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/CH-USA-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-3-auf-dem-weg-vom-zuchtbetrieb-zum-labor-steht-das-tierwohl-an-erster-stelle/ 2026-03-03T08:52:37+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/en/blog/blogserie-amr-awareness-week-2022-teil-3-msd-one-health/ 2026-03-03T08:52:48+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/iStock-186805315-1-e1636638330930.jpg https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-2-notwendige-tierversuche-und-die-ubertragbarkeit-der-ergebnisse-auf-den-menschen-ii/ 2026-03-03T08:53:06+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-1-notwendige-tierversuche-und-die-uebertragbarkeit-der-ergebnisse-auf-den-menschen/ 2026-03-03T08:53:18+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/en/blog/3-fragen-an-leila-schwery-bou-diab-vorsitzende-des-innovation-hub-committee-von-interpharma-vp-manufacturing-technical-operations-janssen-johnson-johnson/ 2026-03-03T08:53:30+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Leila-picture.jpg https://www.interpharma.ch/en/blog/3-fragen-an-urs-voegeli-managing-director-janssen-schweiz-vp-johnson-johnson-schweiz-2/ 2026-03-03T08:53:44+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/klein_JANSSEN-CILAG-URS-VOeGELI18412.jpg https://interpharma.ch/wp-content/uploads/2022/06/klein_JANSSEN-CILAG-URS-VOeGELI18412.jpg https://www.interpharma.ch/en/blog/3-fragen-an-leila-schwery-bou-diab/ 2026-03-03T08:53:55+00:00 https://www.interpharma.ch/wp-content/uploads/2022/06/Leila-picture.jpg https://www.interpharma.ch/en/blog/sichere-supply-chains-europa-muss-zusammenarbeiten/ 2026-03-03T08:54:06+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/en/blog/3-fragen-an-colleen-kamrad-vice-president-general-manager-gsk-switzerland/ 2026-03-03T08:54:18+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-056-scaled.jpeg https://www.interpharma.ch/wp-content/uploads/2026/02/image-17.png https://www.interpharma.ch/en/blog/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes/ 2026-03-03T08:54:42+00:00 https://www.interpharma.ch/wp-content/uploads/2020/02/buholzer_portrait.jpeg https://www.interpharma.ch/en/blog/unser-engagement-in-der-besonderen-lage-diagnostika-medikamente-impfstoffe/ 2026-03-03T08:59:23+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/F%C3%BChrend-in-Wissenschaft-und-Forschung.jpg https://www.interpharma.ch/en/blog/unser-engagement-in-der-besonderen-lage-5-5-produktionsstandort/ 2026-03-03T09:00:13+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_05.jpg https://www.interpharma.ch/wp-content/uploads/2020/11/Animal-Welfare-Report-2021-EN1.pdf https://www.interpharma.ch/en/blog/neue-zahlen-und-fakten-zum-gesundheitswesen-und-zur-pharmalandschaft-schweiz/ 2026-03-03T09:00:31+00:00 https://www.interpharma.ch/wp-content/uploads/2022/09/thmb-Panorama.png https://www.interpharma.ch/en/blog/three-questions-to-johanna-friedl-naderer-president-europe-canada-partner-markets-biogen/ 2026-03-03T09:00:53+00:00 https://www.interpharma.ch/wp-content/uploads/2020/06/Johanna-Naderer.jpg https://www.interpharma.ch/wp-content/uploads/2019/04/AdobeStock_136935043-scaled.jpeg https://www.interpharma.ch/en/blog/three-questions-to-nicholas-franco-from-johnson-johnson/ 2026-03-03T09:01:13+00:00 https://www.interpharma.ch/wp-content/uploads/2020/06/Nicolas-Franco-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2022/12/Komplexitaet_iStock-1061344204.jpg https://www.interpharma.ch/en/blog/three-questions-for-the-new-chair-of-the-market-committee-myriam-deleone-managing-director-of-amgen-switzerland/ 2026-03-03T09:21:25+00:00 https://www.interpharma.ch/wp-content/uploads/add-from-server-reloaded/L1040074-2-Bearbeitet-scaled-e1765550553239.jpg https://interpharma.ch/wp-content/uploads/2025/12/L1040074-2-Bearbeitet-683x1024.jpg https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-2-the-quiet-advance-of-antimicrobial-resistance-amr/ 2026-03-03T09:23:12+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Blog-thumbnail-scaled.png https://www.interpharma.ch/en/blog/press-release-bilaterals-iii-stable-relationships-with-our-principal-trading-partner/ 2026-03-03T09:25:21+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/en/blog/press-release-research-based-industries-acknowledge-the-signing-of-free-trade-agreement-with-mercosur/ 2026-03-03T09:25:41+00:00 https://www.interpharma.ch/wp-content/uploads/2025/07/EFTA-Mercosur.jpg https://interpharma.ch/wp-content/uploads/2025/07/image-2.png https://www.interpharma.ch/en/blog/press-release-switzerland-continues-to-lose-ground-in-access-to-new-medicines-supply-and-location-at-risk/ 2026-03-03T09:25:59+00:00 https://www.interpharma.ch/wp-content/uploads/2021/02/iStock-1064859060-scaled.jpg https://www.interpharma.ch/en/blog/three-questions-to-our-new-board-members-president-region-europe-at-novartis-und-vice-president-of-the-interpharma-board/ 2026-03-03T09:26:22+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/Beitragsbild_3-Fragen-an-Iris-Zemzoum.png https://interpharma.ch/wp-content/uploads/2025/06/Photo-Iris-Zemzoum-2.jpg https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-saur-country-general-manager-switzerland-astrazeneca/ 2026-03-03T09:26:43+00:00 https://www.interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-scaled.jpg https://interpharma.ch/wp-content/uploads/2025/06/AZ_Florian-Saur_1-1024x683.jpg https://www.interpharma.ch/en/?p=12066 2026-03-03T09:26:55+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild_Annette-Luther_3-Fraqgen-an.png https://interpharma.ch/wp-content/uploads/2025/05/Annette_Luther_Roche_02-1-819x1024.jpg https://www.interpharma.ch/en/blog/three-questions-to-our-new-board-members-linn-mandahl-vice-president-europe-region-south-at-abbvie/ 2026-03-03T09:27:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-Linn-Mandahl-1.png https://interpharma.ch/wp-content/uploads/2025/05/Linn-Mandahl-3-683x1024.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-members-david-traub-managing-director-of-novartis-pharma-schweiz-ag/ 2026-03-03T09:27:19+00:00 https://www.interpharma.ch/wp-content/uploads/2025/05/Beitragsbild-3-Fragen-an-David-Traub-1.png https://interpharma.ch/wp-content/uploads/2025/05/David-Traub-3-748x1024.jpg https://www.interpharma.ch/en/blog/prevention-in-the-swiss-healthcare-system/ 2026-03-03T09:28:04+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Les-reins-suffrent-en-silence-1.png https://interpharma.ch/wp-content/uploads/2025/04/Les-reins-suffrent-en-silence-1024x439.png https://www.interpharma.ch/en/blog/access-to-innovation-in-prevention-and-early-detection/ 2026-03-03T09:28:13+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/iStock_Herz_Praevention.jpg https://www.interpharma.ch/en/blog/use-of-data-as-a-key-to-more-targeted-prevention/ 2026-03-03T09:28:22+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/NF_AI4HealthyCities_Skyline_Banner-scaled.jpg https://www.interpharma.ch/en/blog/holistic-strategy-and-coordination/ 2026-03-03T09:28:29+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Bild_Blogbeitrag-2.png https://www.interpharma.ch/en/blog/targeted-prevention-and-early-detection-are-the-key-to-long-term-success/ 2026-03-03T09:28:38+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Beitragsbild-franzoesisch-1.png https://www.interpharma.ch/en/blog/prevention-as-part-of-a-sustainable-swiss-healthcare-system/ 2026-03-03T09:28:49+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Prinzipien-des-Gesundheitswesens_slide_FR-scaled.png https://www.interpharma.ch/en/blog/pharmaceutical-industry-day-2025-making-the-swiss-pharmaceutical-industry-more-competitive/ 2026-03-03T09:29:24+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/bild_schweiz-EU_kachel_380x150.jpg https://www.interpharma.ch/en/blog/medienmitteilung-daiichi-sankyo-wird-mitglied-bei-interpharma/ 2026-03-03T09:29:38+00:00 https://www.interpharma.ch/wp-content/uploads/2025/04/Ausschnitt-Jahresbericht-2024.jpg https://www.interpharma.ch/en/blog/lung-on-chip-eine-humane-loesung-zur-pruefung-von-lungenfunktion-und-toxizitaet/ 2026-03-03T09:30:51+00:00 https://www.interpharma.ch/wp-content/uploads/2025/01/2021-3RCC-026-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-9-neue-therapien-im-fokus-wie-bahnbrechende-tierversuchsfreie-forschung-den-weg-zur-behandlung-der-fettleber-ebnet/ 2026-03-03T09:31:47+00:00 https://www.interpharma.ch/wp-content/uploads/2024/11/BIld-Artikel-9-Liver_organoid-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-8-koennen-insekten-emotionen-empfinden-neue-studien-entfachen-eine-debatte-ueber-die-schmerzempfindlichkeit-wirbelloser-lebewesen/ 2026-03-03T09:31:53+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-8-AdobeStock_741829926-scaled.jpeg https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-7-neue-methode-simuliert-echte-gewebestrukturen-ein-grosser-schritt-fuer-die-zukunft-der-krebsforschung/ 2026-03-03T09:32:11+00:00 https://www.interpharma.ch/wp-content/uploads/2024/10/Artikel-7-pdac_ck7_dapi_day13.png https://www.interpharma.ch/en/blog/blogserie-mit-dem-3rcc-teil-6-wachstumswunder-wie-radial-verteilte-stammzellen-das-wachstum-von-organoiden-foerdern/ 2026-03-03T09:33:01+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Bild-Artikel-6-OCTOPUS-THUMBNAIL.png https://www.interpharma.ch/en/blog/sommerblogserie-mit-dem-3rcc-teil-5-3d-gedrucktes-modell-revolutioniert-die-krebsforschung/ 2026-03-03T09:33:13+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/iStock-1530776415.jpg https://www.interpharma.ch/en/blog/hightech-pharmaproduktion-in-der-schweizer-pharmaindustrie-innovation-und-effizienz/ 2026-03-03T09:33:28+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/Anzeigebild-F.jpg https://www.interpharma.ch/en/blog/naeher-an-der-loesung-des-praeeklampsie-raetsels-in-vitro-trophoblastzellen-in-aktion/ 2026-03-03T09:33:38+00:00 https://www.interpharma.ch/wp-content/uploads/2024/09/2023-Swiss3RCC-003-low.jpg https://www.interpharma.ch/en/blog/press-release-health-panorama-2024-fact-based-contribution-to-the-dialogue-for-a-sustainable-healthcare-system/ 2026-03-03T09:33:58+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/Front-FR.png https://interpharma.ch/wp-content/uploads/2024/08/en-bref-1024x691.png https://www.interpharma.ch/en/blog/medienmitteilung-europabefragung-2024-die-schweizer-stimmbevoelkerung-steht-klar-hinter-den-bilateralen-und-zeigt-sich-kompromissbereit/ 2026-03-03T09:34:34+00:00 https://www.interpharma.ch/wp-content/uploads/2024/03/CH_EU_generisch-klein-scaled.jpg https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-3-das-gehirn-und-die-zeit-was-fruchtfliegen-uns-verraten/ 2026-03-03T09:34:51+00:00 https://www.interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm.png https://interpharma.ch/wp-content/uploads/2024/08/FlyCircadianRhythm-1024x576.png https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-2-erforschung-von-blutstammzellen-erkenntnisse-aus-bildgebenden-verfahren-ueber-die-entwicklung-von-zebrafischen/ 2026-03-03T09:36:53+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/en/blog/sommerblogserie-zusammen-mit-dem-3rcc-teil-1-wie-darmbakterien-das-sozialverhalten-von-zebrafischen-beeinflussen/ 2026-03-03T09:37:11+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://interpharma.ch/wp-content/uploads/2024/07/Zebrafisch.png https://www.interpharma.ch/en/blog/3-fragen-an-unsere-neuen-boardmitglieder-florian-schick-president-merck-switzerland/ 2026-03-03T09:37:25+00:00 https://www.interpharma.ch/wp-content/uploads/2024/07/Schick_1_klein.jpg https://interpharma.ch/wp-content/uploads/2024/07/Schick_1-1024x1024.jpg https://www.interpharma.ch/en/blog/serie-sustainable-development-goals-johnson-johnson-engagiert-sich-fuer-klimaschutz-mit-konkreten-projekten/ 2026-03-03T09:42:48+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-076-scaled.jpg https://www.interpharma.ch/en/blog/health-panorama-2023-heres-to-another-90-years-of-innovation-and-quality-for-the-healthcare-system/ 2026-03-03T09:43:26+00:00 https://www.interpharma.ch/wp-content/uploads/2023/08/Cover-FR.png https://interpharma.ch/wp-content/uploads/2023/08/Bullets-FR.png https://www.interpharma.ch/en/blog/internationaler-tag-der-klinischen-forschung-3-fragen-an-prof-dr-med-miklos-pless-praesident-sakk/ 2026-03-03T09:44:19+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/Pless-Miklos.jpg https://www.interpharma.ch/en/blog/3-fragen-an-thorsten-hein-mitglied-interpharma-board-und-country-division-head-pharmaceuticals-bayer-schweiz/ 2026-03-03T09:44:43+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/ThorstenHein.neu_.png https://www.interpharma.ch/en/blog/3-fragen-an-graham-dorey-mitglied-interpharma-board-und-general-manager-schweiz-biogen/ 2026-03-03T09:44:52+00:00 https://www.interpharma.ch/wp-content/uploads/2023/05/dorey_741_highres-1-scaled.jpg https://www.interpharma.ch/en/blog/3-fragen-an-max-pahlow-mitglied-interpharma-board-und-managing-director-janssen-switzerland/ 2026-03-03T09:45:00+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/klein_MAX-PAHLOW18753.jpg https://www.interpharma.ch/en/blog/medienmitteilung-ueberarbeitung-der-allgemeinen-eu-arzneimittelvorschriften-schwerwiegende-konsequenzen-fuer-die-schweiz-erwartet/ 2026-03-03T09:45:10+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/CH_EU_generisch-scaled.jpg https://www.interpharma.ch/en/blog/3-fragen-an-pierre-morneau-general-manager-takeda-schweiz-takeda-pharma-ag-vice-chair-innovation-hub-committee/ 2026-03-03T09:45:18+00:00 https://www.interpharma.ch/wp-content/uploads/2023/04/896_Interpharma-scaled.jpg https://www.interpharma.ch/en/blog/press-release-interpharma-90-years-of-innovation-and-commitment-to-patients-in-switzerland/ 2026-03-03T09:45:50+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Logo_90-Jahre.jpg https://www.interpharma.ch/en/blog/medienmitteilung-generalversammlung-von-interpharma/ 2026-03-03T09:46:01+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Jahresbericht-2022-Titelbild-EN.jpg https://www.interpharma.ch/en/blog/medienmitteilung-europabefragung-2023-schweizer-bevoelkerung-unterstuetzt-bilaterale-noch-staerker-und-erwartet-vom-bundesrat-einen-konkreten-vorschlag/ 2026-03-03T09:46:10+00:00 https://www.interpharma.ch/wp-content/uploads/2023/03/Europabefragung-2023.jpg https://www.interpharma.ch/en/blog/press-release-a-success-for-switzerland-as-a-production-center-and-for-security-of-supply-in-switzerland/ 2026-03-03T09:47:37+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/CH-USA-scaled.jpg https://www.interpharma.ch/en/blog/trips-briefly-explained/ 2026-03-03T09:47:59+00:00 https://www.interpharma.ch/wp-content/uploads/2021/10/IP-scaled.jpg https://www.interpharma.ch/en/blog/gute-nachrichten-fuer-den-produktionsstandort-schweiz/ 2026-03-03T09:48:08+00:00 https://www.interpharma.ch/wp-content/uploads/2022/12/CH-USA-scaled.jpg https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-3-auf-dem-weg-vom-zuchtbetrieb-zum-labor-steht-das-tierwohl-an-erster-stelle/ 2026-03-03T09:48:48+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/en/blog/blogserie-animal-welfare-report-2022-teil-2-notwendige-tierversuche-und-die-ubertragbarkeit-der-ergebnisse-auf-den-menschen-ii/ 2026-03-03T09:49:00+00:00 https://www.interpharma.ch/wp-content/uploads/2022/11/AWR-22-Website-1.jpg https://www.interpharma.ch/en/blog/neue-zahlen-und-fakten-zum-gesundheitswesen-und-zur-pharmalandschaft-schweiz/ 2026-03-03T10:03:57+00:00 https://www.interpharma.ch/wp-content/uploads/2020/08/Panorama-de-la-Sante.png https://www.interpharma.ch/en/blog/unser-engagement-in-der-besonderen-lage-diagnostika-medikamente-impfstoffe/ 2026-03-03T10:04:36+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_01-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/05/Wertsch%C3%B6pfung.png https://www.interpharma.ch/en/blog/unser-engagement-in-der-besonderen-lage-5-5-produktionsstandort/ 2026-03-03T10:11:35+00:00 https://www.interpharma.ch/wp-content/uploads/2020/07/Interpharma_Titelbild_Home_Icon_05-1.jpg https://www.interpharma.ch/wp-content/uploads/2020/11/Animal_welfare_report_2020_final_d-pdf-1.jpg https://www.interpharma.ch/en/blog/press-release-animal-welfare-report-2023-advancing-the-principles-of-the-3rs-with-the-digitalization-of-animal-research/ 2026-03-03T10:14:29+00:00 https://www.interpharma.ch/wp-content/uploads/2023/11/Animal-Welfare.jpg https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-3-a-success-in-the-fight-against-antibiotic-resistance/ 2026-03-12T13:36:27+00:00 https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-2-the-quiet-advance-of-antimicrobial-resistance-amr/ 2026-03-12T13:46:16+00:00 https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-3-a-success-in-the-fight-against-antibiotic-resistance/ 2026-03-12T14:11:01+00:00 https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-3-a-success-in-the-fight-against-antibiotic-resistance/ 2026-03-12T14:14:09+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Blog-thumbnail-scaled.png https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-1-the-quiet-advance-of-antibiotic-resistance/ 2026-03-12T14:22:01+00:00 https://www.interpharma.ch/wp-content/uploads/2025/11/image-13-3.png https://interpharma.ch/wp-content/uploads/2025/11/image-12.png https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-1-the-quiet-advance-of-antibiotic-resistance/ 2026-03-12T14:23:37+00:00 https://www.interpharma.ch/wp-content/uploads/2021/11/Blog-thumbnail-scaled.png https://interpharma.ch/wp-content/uploads/2025/11/image-15.png https://interpharma.ch/wp-content/uploads/2025/11/image-14.png https://www.interpharma.ch/en/blog/amr-awareness-week-2025-part-1-the-quiet-advance-of-antibiotic-resistance/ 2026-03-12T14:24:38+00:00 https://www.interpharma.ch/wp-content/uploads/2026/02/blog-image-052.png https://interpharma.ch/wp-content/uploads/2025/11/image-17.png https://interpharma.ch/wp-content/uploads/2025/11/image-16.png https://www.interpharma.ch/en/blog/episode-1-a-data-driven-healthcare-system/ 2026-03-17T08:34:49+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-2-reliable-healthcare/ 2026-03-17T08:42:35+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-3-fast-and-equitable-access/ 2026-03-17T08:46:16+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-4-a-research-intensive-and-innovative-healthcare-system/ 2026-03-17T08:49:20+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-6-a-patient-centred-high-quality-healthcare-system/ 2026-03-17T08:53:53+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-7-a-holistic-and-sustainable-health-policy/ 2026-03-17T08:58:24+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-5-the-importance-of-personal-responsibility-and-prevention/ 2026-03-17T09:02:27+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-1-a-data-driven-healthcare-system/ 2026-03-17T09:09:57+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-1-a-data-driven-healthcare-system/ 2026-03-17T09:12:35+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-2-reliable-healthcare/ 2026-03-17T09:21:45+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-2-reliable-healthcare/ 2026-03-17T09:24:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-3-fast-and-equitable-access/ 2026-03-17T09:26:40+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-3-fast-and-equitable-access/ 2026-03-17T09:29:02+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-4-a-research-intensive-and-innovative-healthcare-system/ 2026-03-17T09:31:13+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-4-a-research-intensive-and-innovative-healthcare-system/ 2026-03-17T09:33:34+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-5-the-importance-of-personal-responsibility-and-prevention/ 2026-03-17T09:36:05+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-5-the-importance-of-personal-responsibility-and-prevention/ 2026-03-17T09:38:15+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-6-a-patient-centred-high-quality-healthcare-system/ 2026-03-17T09:43:10+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-7-a-holistic-and-sustainable-health-policy/ 2026-03-17T09:48:22+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-7-a-holistic-and-sustainable-health-policy/ 2026-03-17T09:50:25+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/episode-6-a-patient-centred-high-quality-healthcare-system/ 2026-03-17T09:54:07+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/iph-podcast.png https://www.interpharma.ch/en/blog/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda/ 2026-03-23T14:24:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg https://interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-1024x768.jpg https://www.interpharma.ch/en/blog/medienmitteilung-tag-der-pharmazeutischen-industrie-2026-pharmastandort-schweiz-am-scheideweg/ 2026-03-24T11:52:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/Interpharma_home_hero.webp https://www.interpharma.ch/en/blog/access-to-innovative-medicines-switzerland-continues-to-stagnate-behind-germany/ 2026-05-19T07:15:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Screenshot-2026-05-18-122934.png https://www.interpharma.ch/wp-content/uploads/2026/05/Screenshot-2026-05-18-122934.png https://www.interpharma.ch/wp-content/uploads/2026/05/260518_WAIT_Hist.Entwicklung.png https://www.interpharma.ch/en/blog/access-to-innovative-medicines-switzerland-continues-to-stagnate-behind-germany/ 2026-05-19T07:16:03+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Screenshot-2026-05-18-122934.png https://www.interpharma.ch/wp-content/uploads/2026/05/260518_WAIT_Hist.Entwicklung_EN.png https://www.interpharma.ch/en/blog/access-to-innovative-medicines-switzerland-continues-to-stagnate-behind-germany/ 2026-05-19T07:16:22+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Screenshot-2026-05-18-122934.png https://www.interpharma.ch/wp-content/uploads/2026/05/260518_WAIT_Hist.Entwicklung_F.png https://www.interpharma.ch/en/blog/medienmitteilung-tag-der-pharmazeutischen-industrie-2026-pharmastandort-schweiz-am-scheideweg/ 2026-05-22T07:46:21+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/Interpharma_home_hero.webp https://www.interpharma.ch/en/blog/three-questions-to-our-new-vice-chair-of-the-ecosystem-committee-sec-bairbre-hickie-general-manager-switzerland-takeda/ 2026-05-22T07:47:14+00:00 https://www.interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-1-scaled.jpg https://interpharma.ch/wp-content/uploads/2026/01/BAIRBRE_HICKIE_DSC8736-3-1024x768.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-julian-bertschinger-head-emea-external-scientific-innovation-at-johnson-johnson/ 2026-06-05T14:12:30+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1.png https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1-1.png https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-julian-bertschinger-head-emea-external-scientific-innovation-at-johnson-johnson/ 2026-06-05T14:12:32+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1.png https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1-2.png https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-lauren-mcnamer-general-manager-of-lilly-switzerland/ 2026-06-10T15:17:39+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-lauren-mcnamer-general-manager-of-lilly-switzerland/ 2026-06-10T15:17:41+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-lauren-mcnamer-general-manager-of-lilly-switzerland/ 2026-06-10T15:17:42+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Lauren-McNamer_3MB-file-size-scaled.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-rea-lal-country-lead-of-pfizer-switzerland/ 2026-06-17T14:35:20+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait-1.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-rea-lal-country-lead-of-pfizer-switzerland/ 2026-06-17T14:35:23+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-jerome-garcin-general-manager-for-switzerland-and-austria-bei-bristol-myers-squibb/ 2026-06-22T11:42:21+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-2.jpg https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-edited.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-jerome-garcin-general-manager-for-switzerland-and-austria-bei-bristol-myers-squibb/ 2026-06-22T11:43:46+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-2.jpg https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-edited.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-jerome-garcin-general-manager-for-switzerland-and-austria-bei-bristol-myers-squibb/ 2026-06-22T11:46:19+00:00 https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-2.jpg https://www.interpharma.ch/wp-content/uploads/2026/05/Jerome_Garcin_%C2%A9-BMS-Switzerland-edited.jpg https://www.interpharma.ch/en/blog/medienmitteilung-tag-der-pharmazeutischen-industrie-2026-pharmastandort-schweiz-am-scheideweg/ 2026-06-22T13:47:04+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/Interpharma_home_hero.webp https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-rea-lal-country-lead-of-pfizer-switzerland/ 2026-06-24T08:01:40+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/Reas-Portrait-2.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-michele-ravara-general-manager-abbvie-switzerland/ 2026-06-26T10:14:56+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/ABBVIE_Michele-Ravara.jpg https://www.interpharma.ch/wp-content/uploads/2026/06/ABBVIE_Michele-Ravara_90432-1.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-michele-ravara-general-manager-abbvie-switzerland/ 2026-06-26T10:15:31+00:00 https://www.interpharma.ch/wp-content/uploads/2026/03/ABBVIE_Michele-Ravara.jpg https://www.interpharma.ch/wp-content/uploads/2026/03/ABBVIE_Michele-Ravara.jpg https://www.interpharma.ch/en/blog/3-questions-to-our-new-board-member-julian-bertschinger-head-emea-external-scientific-innovation-at-johnson-johnson/ 2026-06-26T12:15:11+00:00 https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1.png https://www.interpharma.ch/wp-content/uploads/2026/06/Julian-Bertschinger_1.png